David J Hellerstein

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA Columbia University College of Physicians and Surgeons, New York, NY, USA Electronic address
    J Affect Disord 210:258-264. 2016
  2. pmc "The City of the Hospital": On Teaching Medical Students to Write
    David J Hellerstein
    Department of Psychiatry, New York State Psychiatric Institute, Columbia University, 1051 Riverside Drive, Unit 51, New York, NY, 10032, USA
    J Med Humanit 36:269-89. 2015
  3. doi request reprint Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY Columbia University College of Physicians and Surgeons, New York, NY Electronic address
    Compr Psychiatry 57:140-7. 2015
  4. doi request reprint A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression
    David J Hellerstein
    Depression Evaluation Service, Department of Clinical Therapeutics, New York State Psychiatric Institute, NY 10032, USA
    J Clin Psychiatry 73:984-91. 2012
  5. pmc The impact of comorbid dysthymic disorder on outcome in personality disorders
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 51:449-57. 2010
  6. doi request reprint Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Affect Disord 127:84-8. 2010
  7. pmc Assessing behavioral coping preferences of psychiatric inpatients: a pilot study
    David J Hellerstein
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA
    Medscape J Med 10:271. 2008
  8. doi request reprint Escitalopram versus placebo in the treatment of dysthymic disorder
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York 10032, USA
    Int Clin Psychopharmacol 25:143-8. 2010
  9. pmc Antidepressants normalize the default mode network in patients with dysthymia
    Jonathan Posner
    Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York, New York 10032, USA
    JAMA Psychiatry 70:373-82. 2013
  10. doi request reprint Behavioral activation therapy for remediating persistent social deficits in medication-responsive chronic depression
    GREGORY ERICKSON
    Columbia University, New York, NY, USA
    J Psychiatr Pract 17:161-9. 2011

Detail Information

Publications19

  1. doi request reprint Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA Columbia University College of Physicians and Surgeons, New York, NY, USA Electronic address
    J Affect Disord 210:258-264. 2016
    ..To determine efficacy of continued treatment with the serotonin norepinephrine reuptake inhibitor duloxetine on symptom reduction and functional improvement in outpatients with dysthymia...
  2. pmc "The City of the Hospital": On Teaching Medical Students to Write
    David J Hellerstein
    Department of Psychiatry, New York State Psychiatric Institute, Columbia University, 1051 Riverside Drive, Unit 51, New York, NY, 10032, USA
    J Med Humanit 36:269-89. 2015
    ..This special section includes selected works from class members. ..
  3. doi request reprint Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY Columbia University College of Physicians and Surgeons, New York, NY Electronic address
    Compr Psychiatry 57:140-7. 2015
    ..We adapted and tested Behavioral Activation therapy with a goal of return to work (BA-W) in subjects with chronic depression who had responded to medication treatment but remained unemployed...
  4. doi request reprint A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression
    David J Hellerstein
    Depression Evaluation Service, Department of Clinical Therapeutics, New York State Psychiatric Institute, NY 10032, USA
    J Clin Psychiatry 73:984-91. 2012
    ..However, there are no double-blind, placebo-controlled studies of serotonin-norepinephrine reuptake inhibitors in chronic depressive disorder...
  5. pmc The impact of comorbid dysthymic disorder on outcome in personality disorders
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 51:449-57. 2010
    ..The goal of our study was to investigate the impact of dysthymic disorder (DD), a form of chronic depression, on naturalistic outcome in individuals with personality disorders (PDs)...
  6. doi request reprint Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Affect Disord 127:84-8. 2010
    ..We hypothesized that individuals with chronic low-grade depression, dysthymic disorder, would have more impaired functioning than individuals with acute major depression or the general population...
  7. pmc Assessing behavioral coping preferences of psychiatric inpatients: a pilot study
    David J Hellerstein
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA
    Medscape J Med 10:271. 2008
    ..Individual crisis management strategies may be one way to reduce restraint and seclusion, which may include active engagement of inpatients in behavioral coping plans...
  8. doi request reprint Escitalopram versus placebo in the treatment of dysthymic disorder
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York 10032, USA
    Int Clin Psychopharmacol 25:143-8. 2010
    ..A larger study sample or higher escitalopram dose may show more significant placebo-medication differences...
  9. pmc Antidepressants normalize the default mode network in patients with dysthymia
    Jonathan Posner
    Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York, New York 10032, USA
    JAMA Psychiatry 70:373-82. 2013
    ..Moreover, the effect of antidepressant medications on DMN connectivity in patients with DD is also unknown...
  10. doi request reprint Behavioral activation therapy for remediating persistent social deficits in medication-responsive chronic depression
    GREGORY ERICKSON
    Columbia University, New York, NY, USA
    J Psychiatr Pract 17:161-9. 2011
    ..Preliminary evidence suggests that the therapy can be easily implemented with few modifications to improve social and occupational difficulties...
  11. doi request reprint Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
    Vito Agosti
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 50:491-5. 2009
    ..Elevated rates of PD have been noted in early-onset and chronic forms subtypes of depression. However, scant data exist regarding the link between PD and outcome for this depression subtype...
  12. ncbi request reprint Longitudinal comparison of depressive personality disorder and dysthymic disorder
    John C Markowitz
    New York State Psychiatric Institute and Columbia University, New York, NY 10032, USA
    Compr Psychiatry 46:239-45. 2005
    ..The authors attempted to replicate findings of Klein and Shih in longitudinally followed patients with personality disorder or major depressive disorder (MDD) in the Collaborative Longitudinal Personality Disorders Study...
  13. doi request reprint Predicting falls among psychiatric inpatients: a case-control study at a state psychiatric facility
    Irene Estrin
    Department of Psychiatry, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA
    Psychiatr Serv 60:1245-50. 2009
    ..The purpose of the study was to add to the research on risk of falling in an understudied population of psychiatric inpatients in an acute setting...
  14. doi request reprint Divergent fates of the medical humanities in psychiatry and internal medicine: should psychiatry be rehumanized?
    Bret R Rutherford
    Department of Psychiatry, NY State Psychiatric Institute, New York, NY 10032, USA
    Acad Psychiatry 32:206-13. 2008
    ....
  15. pmc Neurocognitive predictors of antidepressant clinical response
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA Division of Cognitive Neuroscience, New York State Psychiatric Institute, New York, NY, USA Electronic address
    J Affect Disord 166:108-14. 2014
    ..Executive dysfunction and psychomotor slowing in depressed patients have been associated with poor antidepressant clinical response, but little is known about the value of neurocognitive tests for differential prediction of response...
  16. ncbi request reprint Citalopram in the treatment of dysthymic disorder
    David J Hellerstein
    New York State Psychiatric Institute, New York, New York 10032, USA
    Int Clin Psychopharmacol 19:143-8. 2004
    ..Double-blind prospective studies are needed comparing citalopram both to placebo and to other medications, assessing both initial and sustained response to treatment...
  17. ncbi request reprint Rating dysthymia: an assessment of the construct and content validity of the Cornell Dysthymia Rating Scale
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    J Affect Disord 71:85-96. 2002
    ..The purpose of this study was to compare these instruments in an outpatient sample of dysthymic patients...
  18. ncbi request reprint Decreasing the use of restraint and seclusion among psychiatric inpatients
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Psychiatr Pract 13:308-17. 2007
    ..Our hypotheses were that interventions could reduce the number of patients as well as patient hours in restraint and seclusion, without an increase in adverse outcomes (fights/assaults, staff injuries, and elopements)...
  19. ncbi request reprint Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting
    David J Hellerstein
    New York State Psychiatric Institute, Harkness Pavilion, 180 Fort Washington Ave, New York, NY 10032, USA
    Psychiatr Q 78:171-81. 2007
    ....